US 12,443,053 B2
Myopia control treatments
Leonard Zheleznyak, Pittsford, NY (US); and Gustavo A. Gandara-Montano, Rochester, NY (US)
Assigned to Clerio Vision, Inc., Rochester, NY (US)
Filed by Clerio Vision, Inc., Rochester, NY (US)
Filed on Mar. 16, 2023, as Appl. No. 18/122,634.
Claims priority of provisional application 63/397,128, filed on Aug. 11, 2022.
Claims priority of provisional application 63/321,447, filed on Mar. 18, 2022.
Prior Publication US 2023/0296919 A1, Sep. 21, 2023
Int. Cl. G02C 7/04 (2006.01)
CPC G02C 7/044 (2013.01) [G02C 2202/24 (2013.01)] 30 Claims
OG exemplary drawing
 
1. An ophthalmic lens configured to inhibit progression of myopia in a user having a retina comprising a central retina and a peripheral retina, the ophthalmic lens comprising:
a central zone; and
an annular zone surrounding the central zone and comprising a first annular sector configured to provide a first myopia inhibiting wavefront correction to light from a first peripheral vision region of a peripheral visual field of the user, wherein the first annular sector is configured so that light from the first peripheral vision region passes through the first annular sector to form an image of the first peripheral vision region on a first annular region of the peripheral retina, wherein the first myopia inhibiting wavefront correction is configured to reduce a first circumferential-to-radial aspect ratio of the image of the first peripheral vision region, and wherein the first circumferential-to-radial aspect ratio is defined as a circumferential length of the image of the first peripheral vision region in a first circumferential direction of the retina divided by a radial length of the image of the first peripheral vision region in a first radial direction of the peripheral retina.